Validation of the HFA-ICOS cardio-oncology cardiovascular risk calculator in an Australian cancer cohort receiving anthracyclines and HER2 targeted therapies
Event:
ESC Cardio-Oncology 2025
Topic:
Stratification, Prevention and Monitoring
Session:
Poster session (1)
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
